Physician profile
Martijn Figee
NPI 1477196822
$31,966.36
in general payments reported to CMS, 2019-2025
9 companies · $11K in 2025
The $11K reported for 2025 was more than what 96% of Psychiatry providers received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $313 · 2020: $29.27 · 2021: $429 · 2022: $1,812 · 2023: $1,978 · 2024: $17K · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $14K · Honoraria: $5,200 · Food and Beverage: $4,155 · Travel and Lodging: $3,011 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,700 · Education: $16.88.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $14,300.00 |
| Honoraria | $5,200.00 |
| Food and Beverage | $4,154.80 |
| Travel and Lodging | $3,011.38 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,700.00 |
| Education | $16.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $16,719.57 | 2023-2025 | Infinity, Proclaim, Prodigy |
| Livanova USA, INC. | $6,691.28 | 2021-2024 | Vns Therapy Symmetry Model 8103 Generator |
| Medtronic, INC. | $4,639.87 | 2021-2025 | Percept PC Brainsense |
| Neurocrine Biosciences, INC. | $2,217.89 | 2021-2025 | Ingrezza |
| Acadia Pharmaceuticals INC | $1,069.11 | 2019-2025 | Nuplazid |
| Boston Scientific Corporation | $255.27 | 2024-2025 | General - Dbs |
| Insightec,INC | $176.79 | 2022 | |
| Medtronic USA, INC. | $134.36 | 2019-2020 | |
| Neuronetics, INC. | $62.22 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Martijn Figee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.